HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Gavin P Robertson Selected Research
Gavin P Robertson Research Topics
Disease
64
Neoplasms (Cancer)
04/2024 - 07/2004
56
Melanoma (Melanoma, Malignant)
03/2022 - 06/2003
7
Neoplasm Metastasis (Metastasis)
01/2021 - 08/2006
5
Carcinogenesis
01/2019 - 06/2003
4
Skin Neoplasms (Skin Cancer)
10/2017 - 04/2007
2
Inflammation (Inflammations)
01/2022 - 06/2010
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 10/2015
2
Leukemia
01/2020 - 10/2015
2
Niemann-Pick Diseases (Niemann Pick Disease)
08/2017 - 01/2017
2
Nevus (Nevi)
08/2010 - 05/2008
2
Breast Neoplasms (Breast Cancer)
06/2008 - 01/2008
2
Tuberous Sclerosis (Bourneville's Disease)
09/2006 - 07/2004
1
Ulcerative Colitis
01/2024
1
Multiple Myeloma
01/2022
1
Disease Susceptibility (Diathesis)
01/2021
1
Hematologic Neoplasms (Hematological Malignancy)
01/2020
1
Malaria
08/2015
Drug/Important Bio-Agent (IBA)
35
Proteins (Proteins, Gene)
FDA Link
02/2024 - 06/2003
13
Phosphotransferases (Kinase)
IBA
03/2022 - 03/2005
13
Mitogen-Activated Protein Kinases
IBA
07/2014 - 09/2003
12
Small Interfering RNA (siRNA)
IBA
09/2014 - 10/2004
8
Cholesterol
IBA
03/2022 - 07/2014
7
Protein Isoforms (Isoforms)
IBA
01/2022 - 10/2004
6
Enzymes
IBA
02/2020 - 09/2008
6
Selenium
IBA
07/2012 - 05/2008
5
dehydroabietylamine
IBA
04/2017 - 07/2014
4
Drug Combinations
IBA
01/2018 - 07/2012
4
Biomarkers (Surrogate Marker)
IBA
01/2017 - 01/2013
4
Ceramides
IBA
03/2012 - 05/2005
3
Ligands
IBA
01/2022 - 01/2008
3
Calreticulin
IBA
01/2022 - 03/2011
3
Aldehydes
IBA
02/2020 - 10/2019
3
Oxidoreductases (Dehydrogenase)
IBA
02/2020 - 10/2019
3
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
01/2020 - 06/2003
3
Aldehyde Dehydrogenase
IBA
10/2019 - 10/2015
3
Celecoxib (Celebrex)
FDA Link
01/2017 - 01/2013
3
DNA (Deoxyribonucleic Acid)
IBA
10/2015 - 08/2009
3
Phosphatidylinositol 3-Kinases (PI 3 Kinase)
IBA
07/2012 - 08/2009
3
Sulfur
IBA
02/2011 - 03/2009
3
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
06/2008 - 08/2006
2
Indicators and Reagents (Reagents)
IBA
01/2022 - 01/2019
2
Casein Kinase II (Casein Kinase 2)
IBA
01/2020 - 10/2015
2
Proline (L-Proline)
FDA Link
01/2020 - 10/2015
2
Ornithine-Oxo-Acid Transaminase (Ornithine Aminotransferase)
IBA
01/2020 - 10/2015
2
capivasertib
IBA
01/2018 - 01/2017
2
adavosertib
IBA
01/2018 - 01/2017
2
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
10/2017 - 01/2008
2
Cyclins
IBA
01/2017 - 01/2017
2
plumbagin
IBA
01/2017 - 01/2017
2
Phosphatidylinositols (Phosphatidylinositol)
IBA
07/2014 - 12/2009
2
Mutant Proteins (Protein, Mutant)
IBA
04/2013 - 03/2005
2
Sunscreening Agents (Sunscreens)
IBA
01/2012 - 02/2011
2
Isothiocyanates
IBA
02/2011 - 03/2009
2
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
01/2011 - 07/2010
2
Integrins
IBA
01/2011 - 07/2010
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
06/2010 - 03/2005
2
Tensins
IBA
12/2009 - 06/2003
2
Mitogens
IBA
08/2009 - 01/2008
2
Liposomes (Liposome)
IBA
08/2009 - 05/2005
2
Sorafenib (BAY 43-9006)
FDA Link
06/2008 - 08/2006
2
MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)
IBA
01/2008 - 08/2006
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
09/2006 - 08/2006
2
PTEN Phosphohydrolase (PTEN Phosphatase)
IBA
10/2004 - 06/2003
1
sodium sulfate (sodium bisulfate)
FDA Link
Generic
01/2024
1
Dextrans (Dextran)
FDA Link
01/2024
1
Agammaglobulinaemia Tyrosine Kinase
IBA
01/2022
1
Natural Killer Cell Receptors
IBA
01/2022
1
Immune Checkpoint Inhibitors
IBA
01/2022
1
Programmed Cell Death 1 Receptor
IBA
01/2022
1
Telomerase (Telomerase Reverse Transcriptase)
IBA
01/2021
1
DNA Transposable Elements (Element, IS)
IBA
01/2021
1
Sphingosine-1-Phosphate Receptors
IBA
01/2021
1
Myosin Light Chains (Myosin Essential Light Chain)
IBA
01/2021
1
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2020
1
salubrinal
IBA
01/2020
1
Eukaryotic Initiation Factor-4F (EIF4F)
IBA
01/2020
1
Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)
IBA
01/2020
1
silmitasertib
IBA
01/2020
1
Eukaryotic Initiation Factor-4E
IBA
01/2020
1
4- ((3Z)- 3- ((5- (4- nitrophenyl)furan- 2- yl)methylidene)- 2- oxo- 5- phenylpyrrol- 1- yl)benzoic acid
IBA
01/2020
1
Nucleotides
IBA
01/2019
1
Neoplasm Antigens (Tumor Antigens)
IBA
01/2019
1
piperidine
IBA
01/2018
1
PLIalpha
IBA
01/2018
1
Ketones
IBA
01/2018
1
Sphingomyelin Phosphodiesterase (Sphingomyelinase)
IBA
08/2017
1
Acids
IBA
08/2017
1
abietic acid
IBA
04/2017
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2016
1
Therapeutic Uses
IBA
10/2015
1
Ribosomal Proteins (Ribosomal Protein)
IBA
09/2015
1
RNA Polymerase I (Polymerase I, RNA)
IBA
09/2015
1
Amino Acids
FDA Link
09/2015
1
Abietanes
IBA
08/2015
Therapy/Procedure
21
Therapeutics
04/2024 - 06/2005
3
Drug Therapy (Chemotherapy)
01/2020 - 08/2009
3
Chemoprevention
10/2017 - 02/2011
2
Immunotherapy
01/2022 - 01/2019
1
Traction
04/2020
1
Radiotherapy
10/2019